Trial Profile

A 12-Week, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study Evaluating the Efficacy and Safety of Aliskiren in Patients With Diabetes and Hypertension Not Adequately Responsive to the Combination of Valsartan 160 mg and Hydrochlorothiazide 25 mg.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 12 Feb 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Oct 2011 Results published in the American Journal of Cardiovascular Drugs.
14 Jan 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
11 Nov 2005 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com